Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruanshang Xiji is a Traditional Chinese Medicine (TCM) topical liquid preparation primarily used for the treatment of acute and chronic soft tissue injuries, including sprains, contusions, and localized swelling. It is most notably recognized as a signature in-hospital preparation (医院制剂) developed by the Beijing Hospital of Traditional Chinese Medicine. The formulation typically consists of a decoction or extract of multiple blood-invigorating and stasis-resolving herbs such as *Carthamus tinctorius* (Safflower), *Angelica sinensis*, *Boswellia carterii* (Frankincense), and *Commiphora myrrha* (Myrrh). These components work synergistically to promote local blood circulation, resolve blood stasis, reduce inflammation, and alleviate pain. It is applied externally to the affected area as a wash, soak, or wet compress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ruanshang Xiji.